Fresenius Boosts Growth by Divesting FMC, Reinvesting €524M in Core Healthcare Platforms
Fresenius’s €524 m sale of FMC shares frees capital for hospital and pharma growth, boosting ROI while aligning with Germany’s shift to value‑based care.
4 minutes to read










